Որոնման արդյունքները - Jorge DiMartino
- Ցուցադրվում են 1 - 8 արդյունքները 8
-
1
-
2
Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome Kevin K. Leung, Aaron Nguyen, Tao Shi, Lin Tang, Xiaochun Ni, Laure Escoubet, Kyle J. MacBeth, Jorge DiMartino, James A. Wells
Հրապարակվել է 2018Artigo -
3
The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver Jorge DiMartino, Licia Selleri, David Traver, Meri T. Firpo, Joon Whan Rhee, Roger A. Warnke, Stephen O’Gorman, Irving L. Weissman, Michael L. Cleary
Հրապարակվել է 2001Artigo -
4
A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies Drew Rasco, Kyriakos P. Papadopoulos, Michael Pourdehnad, Anita K. Gandhi, Patrick R. Hagner, Yan Li, Xin Wei, Rajesh Chopra, Kristen Hege, Jorge DiMartino, Kent C. Shih
Հրապարակվել է 2018Artigo -
5
Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 Leukemia Jun-Ping Wei, Mark Wunderlich, Catherine Fox, Sara Álvarez, Juan C. Cigudosa, Jamie Wilhelm, Yi Zheng, José A. Cancelas, Yi Gu, Michael Jansen, Jorge DiMartino, James C. Mulloy
Հրապարակվել է 2008Artigo -
6
The TALE Homeodomain Protein Pbx2 Is Not Essential for Development and Long-Term Survival Licia Selleri, Jorge DiMartino, Jan van Deursen, Andrea Brendolan, Mrinmoy Sanyal, Elles M. J. Boon, Terence D. Capellini, Kevin S. Smith, Joon Whan Rhee, Heike Pöpperl, Gerard C. Grosveld, Michael L. Cleary
Հրապարակվել է 2004Artigo -
7
Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphoma Víctor Moreno, Juan Manuel Sepúlveda-Sánchez, María Vieito, Tatiana Hernández‐Guerrero, Bernard Doger, Omar Saavedra, Olga Ferrero, R. Sarmiento, M. Arias, Juan de Alvaro, Jorge Di Martino, Marlene Zuraek, Tania Sánchez‐Pérez, Ida Aronchik, Ellen Filvaroff, M. Lamba, Bishoy Hanna, Zariana Nikolova, Irene Braña
Հրապարակվել է 2020Artigo -
8
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia Eytan M. Stein, Guillermo Garcia‐Manero, David A. Rizzieri, Raoul Tibes, Jesús G. Berdeja, Michael R. Savona, Mojca Jongen-Lavrenic, Jessica K. Altman, Blythe Thomson, Stephen J. Blakemore, Scott R. Daigle, Nigel J. Waters, A. Benjamin Suttle, Alicia Clawson, Roy M. Pollock, Andrei V. Krivtsov, Scott A. Armstrong, Jorge DiMartino, Eric Hedrick, Bob Löwenberg, Martin S. Tallman
Հրապարակվել է 2018Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Biology
Gene
Genetics
Cancer research
Medicine
Oncology
Cancer
Internal medicine
Leukemia
Myeloid
CD34
Cell biology
Chemotherapy
Haematopoiesis
Immunology
Lymphoma
Myeloid leukemia
Physics
Stem cell
Acute leukemia
Acute lymphocytic leukemia
Adverse effect
Astrobiology
Azacitidine
Cell
Cell culture
Cell cycle
Chromosomal translocation
Chromosome
Cmax